KLK3 and posterior cortical atrophy: Even when the full impact of splicing decisions for CD44 and KLK3 in the onset an evolution of PCa remains elusive, it results interesting to analyze the expression of splicing variants during the progression of the disease in order to develop new and improved diagnostic and therapeutic tools.